Liver disease associated with methotrexate treatment of psoriatic patients.
D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D000630:Aminopterin / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy / Q000209:etiology; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001772:Blood Cell Count; D002455:Cell Division; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology; D004796:Clinical Enzyme Tests; D004261:DNA Replication; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008111:Liver Function Tests; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D013448:Sulfobromophthalein / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism
D013448:Sulfobromophthalein; D013762:Tetrahydrofolate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000630:Aminopterin; D008727:Methotrexate